Counterfeiters beware: WHO shows poor countries how to procure antimalarials
This article was originally published in Scrip
Executive Summary
Establishments that produce substandard or counterfeit antimalarials will find it harder to sell their products to developing countries after the World Health Organization published new guidelines this week spelling out how to buy quality-made artemisinin-based combination therapies (ACTs), the gold standard in treatment.